Trial · NCT00458341
Adverse events62
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 62
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Ataluren 4, 4, and 8 mg/kg | 6 | 30 | |
| other | Abdominal pain | Gastrointestinal disorders | Ataluren 10, 10, and 20 mg/kg | 8 | 30 | |
| other | Diarrhoea | Gastrointestinal disorders | Ataluren 4, 4, and 8 mg/kg | 3 | 30 | |
| other | Diarrhoea | Gastrointestinal disorders | Ataluren 10, 10, and 20 mg/kg | 2 | 30 | |
| other | Nausea | Gastrointestinal disorders | Ataluren 4, 4, and 8 mg/kg | 2 | 30 | |
| other | Nausea | Gastrointestinal disorders | Ataluren 10, 10, and 20 mg/kg | 0 | 30 | |
| other | Vomiting | Gastrointestinal disorders | Ataluren 4, 4, and 8 mg/kg | 1 | 30 | |
| other | Vomiting | Gastrointestinal disorders | Ataluren 10, 10, and 20 mg/kg | 1 | 30 | |
| other | Chest pain | General disorders | Ataluren 4, 4, and 8 mg/kg | 1 | 30 | |
| other | Chest pain | General disorders | Ataluren 10, 10, and 20 mg/kg | 0 | 30 | |
| other | Pyrexia | General disorders | Ataluren 4, 4, and 8 mg/kg | 1 | 30 | |
| other | Pyrexia | General disorders | Ataluren 10, 10, and 20 mg/kg | 2 | 30 | |
| other | Nasopharyngitis | Infections and infestations | Ataluren 4, 4, and 8 mg/kg | 1 | 30 | |
| other | Nasopharyngitis | Infections and infestations | Ataluren 10, 10, and 20 mg/kg | 1 | 30 | |
| other | Rhinitis | Infections and infestations | Ataluren 4, 4, and 8 mg/kg | 7 | 30 | |
| other | Rhinitis | Infections and infestations | Ataluren 10, 10, and 20 mg/kg | 7 | 30 | |
| other | Stenotrophomonas infection | Infections and infestations | Ataluren 4, 4, and 8 mg/kg | 1 | 30 | |
| other | Stenotrophomonas infection | Infections and infestations | Ataluren 10, 10, and 20 mg/kg | 0 | 30 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Ataluren 4, 4, and 8 mg/kg | 2 | 30 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Ataluren 10, 10, and 20 mg/kg | 1 | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00458341/events